MedTrace Logo

Polio NID and Routine EPI Integration Trial Pakistan

NCT01697280 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4560

Last updated 2014-01-16

No results posted yet for this study

Summary

This study aims to assess if pictorial messages promoting routine immunization during supplementary campaigns for oral polio vaccine in areas with poor DTP3 vaccine coverage can improve immunization rates. A cluster randomized trial design in low literature populations will be used.

Conditions

Interventions

BEHAVIORAL

Vaccine promotion messages

The messages will be low-literacy, of very short duration, and will be delivered with the help of pictorial cards. These educational messages will include the following messages: 1. Vaccines can save a child's life 2. Children who are immunized on time are less likely to become ill 3. Unimmunized children can become disabled for life 4. Photograph of the nearest EPI center where vaccines are offered free of charge, as well as its address and timings.

OTHER

Vaccination Verification.

EPI vaccinators/volunteers will identify and record details of un/under-vaccinated children less than 12 months old in households they visit during an NID, and update immunization registries maintained at the local EPI centers so these children can be reached in subsequent outreach activity.

OTHER

Distribution of Plastic Pouches to retain vaccination card

At the start of this project, all EPI centers in the study areas will be provided with plastic pouches to be given to parents of all children coming to EPI centers for vaccinations. These pouches will be used to store a child's immunization card.

Sponsors & Collaborators

Principal Investigators

  • Anita KM Zaidi, MBBS, FAAP · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
14 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Pakistan

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01697280 on ClinicalTrials.gov